Evidence map›Paper›PMID 38633588›Full record

ArticleACS pharmacology & translational science2024

Napyradiomycin B4 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Alveolar Bone Destruction in Experimental Periodontitis.

Ju Ang Kim, Soomin Lim, Geum Jin Kim, Velina Silviani, Jung-Eun Kim, Jong-Sup Bae, Joo-Won Nam, Hyukjae Choi, Eui Kyun Park

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS pharmacology & translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ju Ang KimDepartment of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.
Soomin LimDepartment of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.
Geum Jin KimDepartment of Pharmacology, School of Medicine, Dongguk University, Gyeongju, Gyeong-buk 38066, Republic of Korea.
Velina SilvianiCollege of Pharmacy, Yeungnam University, Gyeongsan, Gyeong-buk 38541, Republic of Korea.
Jung-Eun KimDepartment of Molecular Medicine, CMRI, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Jong-Sup BaeCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.ORCID https://orcid.org/0000-0002-5756-9367
Joo-Won NamCollege of Pharmacy, Yeungnam University, Gyeongsan, Gyeong-buk 38541, Republic of Korea.ORCID https://orcid.org/0000-0001-5502-0736
Hyukjae ChoiCollege of Pharmacy, Yeungnam University, Gyeongsan, Gyeong-buk 38541, Republic of Korea.
Eui Kyun ParkDepartment of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.ORCID https://orcid.org/0000-0001-8006-6402
Kyungpook National University · KRYeungnam University · KRDongguk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unique structure and beneficial biological properties of marine natural products have drawn interest in drug development. Here, we examined the therapeutic potential of napyradiomycin B4 isolated from marine-derived

Identifiers

PMID38633588
PMCPMC11019734
OpenAlexW4393948405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.